Korro Bio is trading 5.5% up at $13.78 as broad U.S. equity markets strengthened on September 11, 2026.

  • The S&P 500, Nasdaq Composite, and Dow Jones Industrial Average each rose more than 1%, supporting biotechnology shares.
  • Korro Bio’s September 9–10 investor conferences were scheduled events; no new company-specific announcement directly explaining the move was found.